Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6889471rdf:typepubmed:Citationlld:pubmed
pubmed-article:6889471lifeskim:mentionsumls-concept:C0037390lld:lifeskim
pubmed-article:6889471lifeskim:mentionsumls-concept:C0373746lld:lifeskim
pubmed-article:6889471lifeskim:mentionsumls-concept:C0068232lld:lifeskim
pubmed-article:6889471lifeskim:mentionsumls-concept:C1963547lld:lifeskim
pubmed-article:6889471lifeskim:mentionsumls-concept:C2348277lld:lifeskim
pubmed-article:6889471pubmed:issue6lld:pubmed
pubmed-article:6889471pubmed:dateCreated1982-12-2lld:pubmed
pubmed-article:6889471pubmed:abstractTextTen popular snuff brands from the USA and Sweden were analyzed for volatile N-nitrosamines (VNA). Seven of these samples contained between 20 and 70 p.p.b. of N-nitrosomorpholine (NMOR), a strong animal carcinogen. Some of the snuff containers which were made of waxed cardboard contained morpholine. This observation and a model study with the container waxes plus [14C]morpholine indicate that NMOR possibly can be formed by way of diffusion of the morpholine into the snuff and subsequent N-nitrosation. The VNA including NMOR (60-1150 p.p.b.) together with N-nitrosodiethanolamine (NDELA; 225-3300 p.p.b.) and the four tobacco-specific N-nitrosamines (TSNA; 1300-80,000 p.p.b.) contribute significantly to the carcinogenic potential of snuff. This tobacco product, although a known human carcinogen, is becoming increasingly popular especially among young people in the USA and Sweden. A recently introduced Swedish brand with individual snuff portions wrapped in aluminum foil was free of VNA (less than 2 p.p.b.) and contained relatively low levels of NDELA (290 p.p.b.) and TSNA (4200 p.p.b.). This indicates that practical approaches towards lowering N-nitrosamine levels in these snuff products are available.lld:pubmed
pubmed-article:6889471pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6889471pubmed:languageenglld:pubmed
pubmed-article:6889471pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6889471pubmed:citationSubsetIMlld:pubmed
pubmed-article:6889471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6889471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6889471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6889471pubmed:statusMEDLINElld:pubmed
pubmed-article:6889471pubmed:issn0143-3334lld:pubmed
pubmed-article:6889471pubmed:authorpubmed-author:HoffmannDDlld:pubmed
pubmed-article:6889471pubmed:authorpubmed-author:ScottJ CJClld:pubmed
pubmed-article:6889471pubmed:authorpubmed-author:BrunnemannK...lld:pubmed
pubmed-article:6889471pubmed:issnTypePrintlld:pubmed
pubmed-article:6889471pubmed:volume3lld:pubmed
pubmed-article:6889471pubmed:ownerNLMlld:pubmed
pubmed-article:6889471pubmed:authorsCompleteYlld:pubmed
pubmed-article:6889471pubmed:pagination693-6lld:pubmed
pubmed-article:6889471pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6889471pubmed:meshHeadingpubmed-meshheading:6889471-...lld:pubmed
pubmed-article:6889471pubmed:meshHeadingpubmed-meshheading:6889471-...lld:pubmed
pubmed-article:6889471pubmed:meshHeadingpubmed-meshheading:6889471-...lld:pubmed
pubmed-article:6889471pubmed:meshHeadingpubmed-meshheading:6889471-...lld:pubmed
pubmed-article:6889471pubmed:meshHeadingpubmed-meshheading:6889471-...lld:pubmed
pubmed-article:6889471pubmed:meshHeadingpubmed-meshheading:6889471-...lld:pubmed
pubmed-article:6889471pubmed:year1982lld:pubmed
pubmed-article:6889471pubmed:articleTitleN-Nitrosomorpholine and other volatile N-nitrosamines in snuff tobacco.lld:pubmed
pubmed-article:6889471pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6889471pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6889471lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6889471lld:pubmed